CNS outcomes in EGFR/ALK wild-type NSCLC patients with brain metastases treated with immune checkpoint inhibitors (ICI).

被引：0
|
作者：
Shultz, David Benjamin
Lau, Sally Cm
Poletes, Christopher
Le, Lisa W.
MacKay, Kate
Shepherd, Frances A.
Bradbury, Penelope Ann
Leighl, Natasha B.
Liu, Geoffrey
Sacher, Adrian G.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14505
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy
    Zhu, Yixiang
    Zhang, Ye
    Hu, Xingsheng
    Wang, Mingzhao
    Wang, Hongyu
    Liu, Yutao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) : 3557 - 3566
  • [42] PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy
    Yixiang Zhu
    Ye Zhang
    Xingsheng Hu
    Mingzhao Wang
    Hongyu Wang
    Yutao Liu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3557 - 3566
  • [43] OS outcomes to anlotinib in patients (pts) with refractory NSCLC of both wild-type (WT) and mutant EGFR.
    Li, Kai
    Han, Baohui
    Wang, Qiming
    Zhang, Li
    Shi, Jianhua
    Wang, Zhehai
    Cheng, Ying
    He, Jianxing
    Shi, Yuankai
    Chen, Weiqiang
    Wang, Xiuwen
    Luo, Yi
    Nan, Kejun
    Jin, Faguang
    Li, Baolan
    Wang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases
    Mabrut, E.
    Mainbourg, S.
    Peron, J.
    Maillet, D.
    Dalle, S.
    Delaruelle, C. Fontaine
    Grolleau, E.
    Clezardin, P.
    Bonnelye, E.
    Confavreux, C. B.
    Massy, E.
    JOURNAL OF BONE ONCOLOGY, 2024, 48
  • [45] Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody
    Yoshiro Nakahara
    Takaji Matsutani
    Yuka Igarashi
    Norikazu Matsuo
    Hidetomo Himuro
    Haruhiro Saito
    Kouzo Yamada
    Kenta Murotani
    Tomoaki Hoshino
    Koichi Azuma
    Tetsuro Sasada
    Cancer Immunology, Immunotherapy, 2021, 70 : 2881 - 2892
  • [46] Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody
    Nakahara, Yoshiro
    Matsutani, Takaji
    Igarashi, Yuka
    Matsuo, Norikazu
    Himuro, Hidetomo
    Saito, Haruhiro
    Yamada, Kouzo
    Murotani, Kenta
    Hoshino, Tomoaki
    Azuma, Koichi
    Sasada, Tetsuro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 2881 - 2892
  • [47] INTRACRANIAL OUTCOMES OF DUAL IMMUNE-CHECKPOINT INHIBITION AND SRS COMBINATION IN PATIENTS WITH MELANOMA AND NSCLC BRAIN METASTASES
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter
    Wan, Zihan
    Niedzwiecki, Donna
    Winter, Sebastian F.
    Dietrich, Jorg
    Salama, April
    Clarke, Jeffrey
    Allen, Karen
    Mullikin, Trey
    Floyd, Scott
    Kirkpatrick, John
    Reitman, Zachary
    NEURO-ONCOLOGY, 2023, 25
  • [48] Impact of EGFR and ALK mutation on the outcomes of non-small cell lung cancer (NSCLC) patients with brain metastases.
    Balasubramanian, Suresh Kumar
    Venur, Vyshak Alva
    Chao, Samuel T.
    Angelov, Lilyana
    Mohammadi, Alireza Mohammad
    Barnett, Gene H.
    Jia, Xuefei
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] CLINICAL FEATURES AND OUTCOMES OF CARDIAC INVOLVEMENT IN PATIENTS WITH CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS <ICI>
    Abou Alaiwi, Sarah
    Nassar, Amin
    Zarif, Talal
    El-Am, Edward
    Denu, Ryan
    Macaron, Walid
    Malvar, Carmel
    Cortellini, Alessio
    Korolewicz, James
    Sackstein, Paul
    Nana, Frank Aboubakar
    Woodford, Rachel
    Long, Georgina V.
    Kwan, Jennifer
    Grynberg, Shirly
    Shapira, Ronnie
    Herrera-Juarez, Mercedes
    Foderaro, Simone
    Vasbinder, Alexi
    Asnani, Aarti
    Tandon, Ankita
    Hayek, Salim
    Neilan, Tomas G.
    Choueiri, Toni
    Naqash, Abdul-Rafeh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2353 - 2353
  • [50] Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
    Kowalski, Emily S.
    Remick, Jill S.
    Sun, Kai
    Alexander, Gregory S.
    Khairnar, Rahul
    Morse, Emily
    Cherng, Hua-Ren
    Berg, Lars J.
    Poirier, Yannick
    Lamichhane, Narottam
    Becker, Stewart
    Chen, Shifeng
    Molitoris, Jason K.
    Kwok, Young
    Regine, William F.
    Mishra, Mark V.
    RADIATION ONCOLOGY, 2020, 15 (01)
12345